Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02897908 · ClinicalTrials.gov registry record

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

A clinical trial of Disease of Liver and Bile Duct, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT02897908: Recruiting study of Disease of Liver and Bile Duct, sponsored by State University of New York at Buffalo.

NCT02897908 is a study of Disease of Liver and Bile Duct that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02897908, a study of Disease of Liver and Bile Duct, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

Primary Outcome

single event per patient with liver disease to measure degree of fibrosis concentration

Interventions

  • PROCEDURE vibration controlled transient elastography (VCTE)

Study Locations (1)

New York

  • Conventus Medical Office Building - Buffalo

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-10-28
Est. Completion 2026-12

What NCT02897908 shows while recruiting

NCT02897908 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Disease of Liver and Bile Duct appearing as the primary indexed condition, and to 1 intervention - of which vibration controlled transient elastography (VCTE) is the first listed.

NCT02897908 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02897908 about?

NCT02897908 is a clinical study titled "Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database". The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

What is the current status of trial NCT02897908?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-10-28. Estimated completion is 2026-12.

What conditions does trial NCT02897908 study?

This clinical trial studies the following conditions: Disease of Liver and Bile Duct.

What interventions are being tested in trial NCT02897908?

The interventions under investigation include: vibration controlled transient elastography (VCTE) (PROCEDURE).

Who is sponsoring clinical trial NCT02897908?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02897908 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02897908, the US trial registry maintained by the National Library of Medicine. NCT02897908 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.